- Call •1-800-455-1141 for Lundbeck Products, except:
- •1-800-438-9927 for• ABILIFY ASIMTUFII® (aripiprazole)• ABILIFY MAINTENA® (aripiprazole)• REXULTI® (brexpiprazole)
- •877-TAKEDA-7 (877-825-3327) for TRINTELLIX® (vortioxetine)
Medical Inquiry
Submit a medical question to the Lundbeck Medical Information support team. Lundbeck is committed to answering questions about Lundbeck prescription products quickly and accurately.
Report an Adverse Event or Product Complaint
If you need to report an adverse event or product complaint in the US, please choose from the following options:
Submit an Online report form
to Lundbeck
Report directly to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch
ABILIFY ASIMTUFII®, ABILIFY MAINTENA® or REXULTI®:
faxmedicalinformation@otsuka-us.com
ABILIFY ASIMTUFII, ABILIFY MAINTENA and REXULTI are registered trademarks of Otsuka Pharmaceutical Co. Ltd. (Japan)
TRINTELLIX®:
TRINTELLIX is a registered trademark of H. Lundbeck A/S and used under license by Takeda Pharmaceuticals.
MORE FROM LUNDBECK
The Latest from Lundbeck
Here you will find media contacts, plus the latest news, stories and insights from Lundbeck US.
Medical Education
Access neurology and psychiatry educational materials and training for healthcare professionals.
Therapies in Development
Discover how our research and development teams work together towards a singular goal to deliver novel therapies aiming to redefine the standard of care for patients.
Clinical Trials
Find information on Lundbeck clinical trials both past and present as well as Lundbeck’s approach to clinical trial information.
